CAS 332863-86-2

MBC-11

CAS : 332863-86-2

MBC-11

Degré de pureté : ≥98%

Masse moléculaire : 511.21g/mol

Ref: 54-BUP04297

MBC-11

CAS : 332863-86-2

MBC-11 is a new drug for the treatment of tuberculosis. It has been shown to have a bactericidal concentration of 0.5-1 ug/ml and a clinical development time of 12-24 months. MBC-11 is an antibody that blocks the interaction between mycobacterium tuberculosis and human platelets by binding to the mycobacterium's cell wall and preventing it from attaching to host cells. MBC-11 also has anti-cancer properties, which may be due to its ability to inhibit cancerous growth by targeting tumor cells through its ability to bind to cancer cells.

Formule : C₁₁H₂₀N₃O₁₄P₃

Degré de pureté : Min. 95%

Masse moléculaire : 511.21 g/mol

Ref: 3D-HNA86386

MBC-11

CAS : 332863-86-2

MBC-11: First bone-targeting bisphosphonate-etidronate conjugate with araC, may treat TIBD.

Formule : C₁₁H₂₀N₃O₁₄P₃

Degré de pureté : >99.99% - >99.99%

Couleur et forme : Solid

Masse moléculaire : 511.21

Ref: TM-T11956L